ANDA 40386, held by Sun Pharma Canada. Triamcinolone Acetonide.
As of Nov 15, 2026, ANDA 40386 (Triamcinolone Acetonide), held by Sun Pharma Canada, was first approved by FDA on Jun 5, 2001, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 5, 2001 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Triamcinolone Acetonide0.5% ยท ointment;topical | Triamcinolone Acetonide | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
